Skip Navigation

Defense Health Agency

"On October 1, 2013, the Department of Defense established the Defense Health Agency (DHA) to manage the activities of the Military Health System. These activities include those previously managed by TRICARE Management Activity (TMA), which was disestablished on the same date. During the next several months, all TMA websites will change to reflect the new DHA. We appreciate your patience during this transition."
 
P&T Meeting Drug Class Price &
Refund Quotes
Due Date
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Amylin Agonist 08 Oct 2010
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Alpha-Glucosidase Inhibitors 08 Oct 2010
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Biguanides 08 Oct 2010
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Dipeptidyl Peptidase 4 (DPP-4) Inhibitors 08 Oct 2010
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Glucagon-like peptide-1 (GLP-1) Receptor Agonists 08 Oct 2010
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Meglitinides 08 Oct 2010
17-18 Nov 2010 DIABETES: NON-INSULIN: Subclass: Thiazolidinediones 08 Oct 2010
17-18 Nov 2010 Designated Newly Approved Drugs 08 Oct 2010

NEW BIDDING MATRIX !

TELECONFERENCE NOTICE

November 2010 DoD P&T Meeting Reviews

The teleconference will be held September 9th, 2010, 9:30 AM to 11:30  Mountain Time.

Manufacturers of pharmaceuticals in the drug classes to be reviewed at the upcoming P&T Committee meeting are invited to participate with DoD in a teleconference to review the quoting process and to address industry questions about these reviews. Interested manufacturers must register by submitting participant's name, company name, and the drug class your product is assigned via email to UFBPA@tma.osd.mil no later than September 07, 2010.

The call-in number and a pre-conference agenda will be emailed to all registered participants. A summary of the teleconference, to include all questions and answers, will be posted at this site following the teleconference.

Advance questions will be addressed during the teleconference if sent to UFBPA@tma.osd.mil by September 08, 2010.

Bid Submission Steps

Step 1:

Download Utilization

Click here to view Utilization Datasheet List


Step 2:


Download and complete the template below.

Click here to view associated UF BPA Appendix List for each NDC.

Uniform Formulary Blanket Purchase Agreement (UF BPA) Template
in Adobe PDF format
(34 KB)

Uniform Formulary Blanket Purchase Agreement (UF BPA) Template
in Microsoft Word format
(109 KB)

Send quote to:

UF BPA Price Quotes
TMA Acquisition and Management Support Directorate will receive BPA price quotes. Send all BPA price quotes to:

Carla McCabe, Contract Specialist
DoD Uniform Formulary BPA
TRICARE Management Activity
16401 East Centretech Parkway
Aurora, CO 80011-9066

Step 3:

Download and complete the template below.

Click here to view associated UF VARR Appendix List for each NDC.

Voluntary Agreement for TRICARE Retail Pharmacy Refunds VARR version 4.0 - (PDF version)
Voluntary Agreement for TRICARE Retail Pharmacy Refunds VARR version 4.0 - (Excel Worksheet version)

Send quote to:

UF VARR Refund Quotes
TMA Pharmacy Program Office will receive UF VARR quotes. Send all VARR quotes to:

Pharmacy Contracting Officer/COD
ATTN: UF VARR
TRICARE Management Activity
16401 East Centretech Parkway
Aurora, CO 80011-9043

NOTICE

For some drug classes, DoD may require companies to submit multiple price and refund quotes contingent upon the number of agents selected to the Uniform Formulary (UF) or Basic Core Formulary (BCF) as defined by the government. Please read carefully the information about submitting multiple quotes in the UF Price and Refund Information, the applicable "Drug Class Pages" that are linked to the Drug Classes Under Review page, the UF BPA Price Quote Template, and the UF VARR Refund Quote Template. Please use the contact Information below for additional questions.

Deadlines

General (all reviews)

UF BPA Quotes

Pharmaceutical companies may submit UF BPA price quotes for pharmaceutical agents in the classes under review that will be used by the DoD P&T Committee as the cost to the government portion of its relative cost effectiveness considerations under 32 CFR 199.21. Signed UF BPA price quotes may be submitted in Adobe PDF file format via e-mail to UFBPA@tma.osd.mil provided the original signed UF BPA quote, identical in every respect, is received by Contracting the next business day. No other electronic format is acceptable. The deadline for submission of signed UF BPA price quotes to TMA Contracting is 1:00 PM EST on the applicable date indicated in the table above. Quotes received after the deadline may be rejected by the Contracting Officer. NOTE: Original quotes will not be accepted via FAX.

The establishment of a UF BPA with a pharmaceutical company for a generic (multi-source) pharmaceutical agent does not establish that pharmaceutical company as the sole source of supply for the pharmaceutical agent. However, in the event of existing Joint DoD/VA contracts, UF BPA quotes will not be accepted for generic (multi-source) pharmaceutical agents.

UF VARR Quotes

Pharmaceutical companies may submit Uniform Formulary Voluntary Agreements for TRICARE Retail Pharmacy Refunds (UF VARR) quotes for pharmaceutical agents in the classes under review that will be used by the DoD P&T Committee as the cost to the government portion of its relative cost effectiveness considerations under 32 CFR 199.21. Signed UF VARR quotes may be submitted in Adobe .PDF file format via e-mail to UF-VARR@amedd.army.mil provided the original signed UF VARR quote, identical in every respect, is received by DoD the next business day. No other electronic format is acceptable. The deadline for submission of signed UF VARR quotes to the DoD is 1:00 PM EST on the applicable date indicated in the table. Quotes received after the deadline may be rejected by the DoD. NOTE: Original quotes will not be accepted via FAX.

UF VARR quotes will not be accepted for generic (multi-source) pharmaceutical agents.

Questions and Submission Information

Please click here for additional information about submitting UF quotes. Direct all questions regarding submission of BPA price quotes to the P&T Committee, to the attention of Carla McCabe, Sr. Contract Analyst, 303-676-3933 phone or email: UFBPA@tma.osd.mil.

Direct all questions regarding submission of UF VARR quotes to the P&T Committee, to the attention of Dr. Dave Meade, phone 210-295-1271 or email: UF-VARR@amedd.army.mil.

The establishment of a UF BPA with a pharmaceutical company for a generic (multi-source) pharmaceutical agent does not establish that pharmaceutical company as the sole source of supply for the pharmaceutical agent. However, in the event of existing Joint DoD/VA contracts, UF BPA quotes will not be accepted for generic (multi-source) pharmaceutical agents.

UF VARR quotes will not be accepted for generic (multi-source) pharmaceutical agents.

The DoD reserves the right to exclude specific formulations or NDCs of a given drug from a submitted UF BPA and/or UF VARR based on recommendations of the P&T Committee and decision of the Director, TMA.